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P Wave Dispersion: A Valuable  
Non-Invasive Marker of Vulnerability  
to Atrial Arrhythmias
Polychronis E. Dilaveris, Christodoulos I. Stefanadis
A B S T R A C T
The prolongation of intraatrial and interatrial conduction time and the non-homoge-
neous propagation of sinus impulses are well known electrophysiologic characteristics 
in patients with atrial arrhythmias and especially paroxysmal atrial fibrillation (AF). 
Previous studies have demonstrated that individuals with clinical history of parox-
ysmal AF show a significantly increased P wave duration in 12-lead surface electro-
cardiograms (ECG) and signal-averaged ECG recordings. The inhomogeneous and 
discontinuous atrial conduction in patients with atrial arrhythmias has been studied, 
during the last years, with a new ECG index, P wave dispersion. P wave dispersion is 
defined as the difference between the longest and the shortest P wave duration record-
ed from multiple different surface ECG leads. Extensive clinical evaluation of P wave 
dispersion has been performed in the assessment of the risk for AF in patients without 
apparent heart disease, in hypertensive patients, in patients with coronary artery dis-
ease, in patients undergoing coronary artery bypass surgery, in patients with congeni-
tal heart diseases, as well as in other groups of patients suffering from various cardiac 
or non-cardiac diseases. P wave dispersion has proven to be a sensitive and specific 
ECG predictor of AF in the various clinical settings. However, the methodology used 
for the calculation of P wave dispersion has not been standardized so far and more ef-
forts to improve the reliability and reproducibility of P wave dispersion measurements 
are needed. In conclusion, P wave dispersion constitutes a significant contribution to 
the field of non-invasive electrocardiology and seems to be quite promising in the field 
of AF prediction.
I N T R O D U C T I O N
Atrial fibrillation (AF) is the most common arrhythmia in clinical practice. One 
of the mechanisms implicated in its pathogenesis is the presence of multiple, randomly 
reentrant wavelets that propagate, become extinct, or fractionate within the atrial 
tissue. The correlation between the presence of atrial conduction abnormalities and 
the induction of paroxysmal AF has been well documented [1]. Although markedly 
prolonged intra- and interatrial conduction time can be recognized by prolongation of 
the surface P wave duration, the question arises as to whether non-homogeneous atrial 
conduction could be identified by variation in P wave duration between differently 
oriented surface ECG leads. Regional delays in atrial depolarization might produce 
a heterogeneous P wave duration because surface P waves in different locations could 
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be affected to a different extent by regional changes in atrial 
activation times. In support of this local hypothesis, a previous 
study has postulated that the electrical activity in the surface 
ECG closely correlates with the conduction in specific parts 
of the atria [2]. The local hypothesis explaining the interlead 
variation in P waves duration, that is the so-called P wave 
dispersion, competes with the global hypothesis explaining 
the variation in surface ECG measurements with different 
projections of a common P-wave vector. Whether the interlead 
variation in P waves duration (P wave dispersion) could be 
attributed to an underlying heterogeneity of atrial conduc-
tion (a local effect), or to a variable projection of a single 
depolarization vector onto different ECG leads (a projection 
phenomenon) and/or to imprecision of measurement when 
the P wave amplitude is low and the P wave onset and offset 
are difficult to define, is not justified from the available, up 
to now, body of evidence. The present review aims to inform 
clinicians about the already gained experience from the use of 
P wave dispersion. Numerous studies from many centers have 
contributed to elucidate the rationale and clinical applicability 
of this new ECG index (Table 1).
Table 1. Predictive Role of P Wave Dispersion in Patients Vulnerable to Atrial Fibrillation
Study Patients
(No.)
Heart
Disease
Electrocardiograph Cutoff
value
(ms)
Sens.
(%)
Spec.
(%)
Type Leads
Dilaveris P. Am Heart J 1998 100 No Thermal 12 40 83 85
Kloter Weber U. Eur Heart J 1998 107 Post-CABG Thermal 12 - - -
Gialafos J. A.N.E. 1999 125 No Digital 12 40 81 80
Dilaveris P. PACE 1999 110 CAD Digital 12 - - -
Chang CM. Int J Cardiol 1999 120 Post-CABG Thermal 12 -   
yamada T. Eur Heart J 1999 112 HD Signal-averaged 16 - - -
Kubara I.J Cardiovasc Electrophysiol 1999 63 HD Signal-averaged 16 - - -
Dilaveris P. PACE 1999 60 HD Digital 12 - - -
Dilaveris P. J Hypertens 1999 110 Hypertension Digital 12 - - -
Dilaveris P. PACE 2000 88 HD Digital 12 - - -
Tukek T. Am J Cardiol 2000 54 HD Thermal 12 - - -
Ciaroni S. Am Heart J 2000 97 Hypertension Thermal 12 40 74 81
Aytemir K. PACE 2000 160 No Thermal 12 36 77 82
Gilligan D. PACE 2000 48 HD Thermal - - -
Andrikopoulos G. PACE 2000 110 No Thermal/Digitized  40 83 85
Fan K. Circulation 2000 132 Post-CABG Thermal - - -
Rosiak M. A.N.E. 2002 130 AMI Thermal 12 25   
Dogan A. J Electrocardiol 2003 96 HD Thermal 12 47 82 83
Kose S. Clin Cardiol 2003 22 HCM Thermal 12 46 76 82
Dogan A. Am J Cardiol 2004 64 HD Thermal 12 46 89 96
Hallioglu O. A.N.E. 2004 25 CTF Digital 12 35 83 89
Ozdemir O. Int J Cardiol 2004 27 HCM Thermal 12 52.5 96 91
Wong T. Circulation 2004 33 Post-Fontan Thermal/Digitized 12 66 79 79
Perzanowski C. J Electrocardiol 2005 81 HD Thermal 12 80 27 88
Boriani G. Int J Cardiol 2005 37 HD Digital 12 25   
Aras D. Int J Cardiol 2005 193 Hyperthyroidism Thermal 12 37.5 90 85
Amasyali B. A.N.E. 2006 72 Post-ablation AVNRT Digital 12 35.5 90 85
AMI = acute myocardial infarction; AVNRT = atrioventricular nodal reentrant tachycardia; CABG = coronary artery bypass surgery; CAD 
= coronary artery disease; CTF = corrected tetralogy of Fallot; HCM = hypertrophic cardiomyopathy; HD = organic heart disease; Sens. = 
sensitivity; Spec. = specificity.
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C L I N I C A L  U S E  O F  P  wAv E  D I S P E R S I O N
In a first attempt to correlate the asynchronous atrial 
conduction with an isoelectric interval derived from surface 
ECG, Buxton and Josephson [3] introduced the isoelectric 
interval, which was derived by subtracting the longest P wave 
duration in the standard limb lead from the total P wave du-
ration, measured from the earliest onset to the latest end of 
the P wave in any of the simultaneously recorded leads I, II, 
and III. This isoelectric interval was found to be significantly 
higher in patients with AF history than in controls, although 
it was not proven to be a sensitive or specific ECG predictor of 
AF [3]. In another study [4], it was postulated that the regional 
differences in the atrial activation found in patients with AF 
history could be reflected in the temporal variation across the 
leads of the filtered orthogonal ECG.
In later studies, a standard 12-lead ECG was generally used 
to obtain the quantity of the largest information concerning 
the interlead variation in the P wave duration. In many of the 
original studies, P wave duration and P wave dispersion were 
calculated from 12-lead ECGs recorded on standard paper 
printed ECGs. P wave dispersion was defined as the difference 
between the shortest and the longest P wave duration in any 
of the 12 ECG leads [5]. In the same study, P wave disper-
sion was found to be significantly higher in 60 patients with 
paroxysmal lone AF (4915ms) than in 40 healthy controls 
(28 7ms, p <0.0001) [5]. P wave dispersion was proven to 
be a sensitive and specific ECG marker for the best separa-
tion between patients with history of paroxysmal lone AF 
and healthy subjects [5]. A cutoff value of 40msec proved to 
have a sensitivity of 83%, a specificity of 85%, and a positive 
predictive accuracy of 89% for the identification of patients 
with history of paroxysmal lone AF [5]. Moreover, during a 
12-month follow-up period, the relative risk of a AF recurrence 
was 2.37 for a P wave dispersion value 40 ms [5]. In another 
publication [6], P wave dispersion was shown to be a sensitive 
and specific ECG predictor of paroxysmal lone AF. In the 
same study, P wave dispersion showed a significant correlation 
with maximum P wave duration (r =0.702, p <0.001) and a 
weak, although significant, association with age (r =0.270, p 
<0.001) [6]. In another study, P wave dispersion was shown 
to be a significant predictor of frequent symptomatic AF 
paroxysms but only in the univariate analysis [7]. In the same 
study, P wave dispersion was found to be significantly cor-
related positively with maximum P wave duration (p <0.001) 
and negatively with minimum P wave duration (p =0.06). It is 
obvious that, when beyond P wave dispersion both maximum 
and minimum P wave duration are incorporated as covariates 
in multivariate regression models, P wave dispersion may not 
remain an independent predictor of AF in the multivariate 
analysis [7,8]. The predictive roles of P wave dispersion after 
cardioversion of AF [9-14], as well as its difference in accor-
dance to the classification of AF episodes [15-17], have been 
verified in several different studies.
Value of P wave dispersion in hypertensive patients
P wave dispersion, adjusted P wave dispersion, that is P 
wave dispersion corrected according to the number of measur-
able leads, and the standard deviation of the P waves duration 
were all found to be significantly higher in 50 hypertensive 
patients with history of paroxysmal AF as compared to 60 
hypertensive patients with no previous history of AF [18]. 
Each of these 3 indices was found to be significantly related 
to the other 2 (correlation coefficients ranging from 0.926 to 
0.998) and all of them were found to be significantly associ-
ated positively with maximum P wave duration (correlation 
coefficients ranging from 0.585 to 0.719) and negatively with 
minimum P wave duration (correlation coefficients ranging 
from –0.289 to –0.460). In another study, P wave dispersion 
was also found to be significantly increased (4814 ms) in 19 
hypertensive patients developing AF during a mean follow-up 
of 253 months when compared to 78 hypertensive patients 
who showed no AF episodes during the follow-up period 
(308 ms, p <0.01) [19]. In the multivariate analysis, P wave 
dispersion was an independent predictor for the onset of AF 
in the hypertensive population (odds ratio 2.81, p <0.001), 
even after correction for age (odds ratio 1.63, p <0.001). No 
significant correlation was found in the same study between 
P wave dispersion and the blood pressure levels, the left atrial 
dimension, the left ventricular mass and the velocity of the A 
wave or the E/A ratio of the diastolic mitral flow [19]. Another 
study also verified the ability of P wave dispersion to predict 
AF in hypertensive patients [20].
Assessment of P wave dispersion in patients 
undergoing open-heart surgery
In one study, it was demonstrated that P wave dispersion 
was significantly increased in 47 patients developing AF after 
coronary artery bypass surgery (4912ms) as compared to 60 
patients with no postoperative AF (4112ms, p =0.0009) [8]. 
P wave dispersion was found to be a significant predictor of 
postoperative AF but only in the univariate analysis [8]. Other 
studies have also postulated the predictive ability of P wave 
dispersion in patients undergoing by-pass surgery [21-24].
Value of P wave dispersion in coronary artery disease 
patients
The effects of myocardial ischaemia on P wave dispersion 
were evaluated in 95 patients with documented coronary 
artery disease and spontaneous angina pectoris [25]. P wave 
dispersion was found to be significantly increased during the 
anginal episodes irrespective of the presence of history of a 
previous myocardial infarction [25]. Furthermore, P wave 
dispersion showed higher values during the anginal episode in 
patients with left ventricular dysfunction, independently of the 
presence of a previous myocardial infarction [25]. Increased 
P wave dispersion values were demonstrated in patients after 
acute myocardial infarction [26-28], in patients with syndrome 
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X [29], or those receiving reperfusion therapies [30].
Estimation of P wave dispersion in patients with 
valvular heart diseases
The presence of increased P wave dispersion values in 
patients with valvular heart diseases [31-33], as well as the 
effects of medical treatment [33], or of balloon valvuloplasty 
on P wave dispersion in patients with mitral stenosis [31], have 
also been demonstrated.
Assessment of P wave dispersion in patients with 
congenital heart diseases
The predictive ability of P wave dispersion in patients with 
congenital heart diseases, before and after surgery was as-
sessed in several studies [34-38]. Wong et al. [37] demonstrated 
that patients with atrial tachyarrhythmias late after Fontan 
operation have longer P-wave duration and P-wave dispersion 
and larger right atrial dimension than those without the ar-
rhythmias; these abnormalities are interrelated. The authors 
of that study concluded that their observation represents an 
atrial mechano-electrical remodeling phenomenon in paral-
lel to an increase in arrhythmia propensity in this vulnerable 
population.
Autonomic tone influences on P wave dispersion
An insight on the modulatory effects of the autonomic tone 
changes on P wave dispersion were previously given by Tukek 
and colleagues [39]. They showed that the Valsalva maneuver 
normalized the increased values of P wave duration and P 
wave dispersion found in patients with history of paroxysmal 
AF and, on the other hand, increased P wave duration and 
dispersion in normal subjects [39]. These findings may imply 
that the Valsalva maneuver decreases the heterogeneity of 
atrial impulse propagation due to changes in the atrial size 
and electrophysiology [39]. The effect of Valsalva maneuver 
on P wave dispersion was also assessed by Altunkeser et al 
[40], while the effect of exercise on this index was reported 
by yigit et al. [41].
Association of P wave dispersion with 
echocardiographic indices
The association of P wave dispersion with left atrial size 
and function [42], left atrial appendage function [43], and left 
ventricular diastolic function [44,45] were provided by several 
investigators. In a recent study [46], Ozer et al. showed that in-
teratrial electromechanical delay gets longer in mitral stenosis 
patients and is correlated with P wave dispersion.
P wave dispersion in other cardiac or non-cardiac 
diseases
The role of P wave dispersion for the prediction of AF 
episodes was also evaluated in patients with chronic obstruc-
tive pulmonary disease [47], in patients with hypertrophic 
cardiomyopathy [48,49], in patients with hyperthyroidism 
[50,51], after radiofrequency catheter ablation of atrioven-
tricular reentrant tachycardia [52,53] or atrioventricular nodal 
reentrant tachycardia [54], in patients with end-stage renal 
failure undergoing hemodialysis [55,56], or in patients under 
chemotherapy regimen [57].
P wave dispersion in normal subjects and associations 
with demographic characteristics
The normal values of P wave dispersion and other P wave 
analysis indices derived from digital 12-lead ECGs were 
defined in a large population of 1,353 young healthy men. 
All ECG indices were significantly associated with the R-R 
interval, and with each other [58]. Moreover, the effect of 
obesity [59], acute caffeine ingestion [60], or alcohol intake 
[61,62], on P wave dispersion in healthy subjects, as well as its 
seasonal changes [63], have been evaluated in several studies. 
Moreover, the differences in these ECG predictors of atrial 
rhythm disturbances between trained athletes and control 
subjects were demonstrated by Karakaya et al. [64].
The effects of pacing on P wave dispersion
Single-site atrial, dual-chamber, as well as septal pacing 
showed controversial results concerning the provoked changes 
in paced P wave dispersion and its power to predict AF. [65-69]. 
High right atrial (Bachman bundle) pacing failed to alter P 
wave dispersion, whereas P wave duration and P wave disper-
sion were not predictive of AF after pacemaker implantation, 
in two studies [66,68]. However, the effects of multi-site atrial 
pacing on P wave dispersion were more promising. Gilligan 
et al. showed that although P wave duration was markedly 
reduced by biatrial pacing in patients with and without history 
of AF and/or flutter, P wave dispersion was unaffected [70]. On 
the contrary, Fan and colleagues showed that biatrial pacing, 
which was more effective in the prevention of postoperative 
AF after coronary artery bypass surgery than single-site atrial 
pacing, resulted in the most significant reduction in mean P 
wave dispersion (428%) when compared with single-site (left 
atrial pacing 136%, right atrial pacing 109%; p <0.05 for 
biatrial versus left or right atrial pacing) atrial pacing [71]. 
Furthermore, P wave dispersion was only reduced in those 
patients whose AF was prevented by pacing therapy [71,72].
Dispersion of the filtered P wave duration
In two studies, it was demonstrated that patients with clini-
cal history of paroxysmal AF show a significantly increased 
dispersion of the signal-averaged P wave duration on the 
precordial body surface [73,74]. The dispersion of the filtered 
P wave duration was calculated as the difference between the 
longest and the shortest filtered P wave recorded from 16 dif-
ferent precordial unipolar leads, and it was found to be the 
most sensitive and specific ECG marker for the prediction 
of AF [73,74]. A significant linear relationship between the 
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dispersion of the filtered P wave duration and filtered P wave 
duration (r =0.71, p <0.0001) was found in one of the 2 studies 
[74]. In the same studies, the dispersion of the signal averaged 
P wave duration was used to assess the efficacy of the antiar-
rhythmic drugs pilsicainide and disopyramide. It was found 
that the dispersion of the filtered P wave decreases after the 
administration of a single oral dose of the antiarrhythmic drug 
in those patients in whom the antiarrhythmic drug is going to 
be effective in the suppression of AF attacks and increases 
in patients showing multiple recurrences of AF [73,74]. The 
criteria of decreased dispersion of filtered P wave duration due 
to a single dose administration of pilsicainide, gave a sensitivity 
of 88%, a specificity of 65%, a positive predictive value of 54% 
and a negative predictive value of 92% for the prediction of 
drug efficacy [73]. Moreover, assessment of P wave dispersion 
and P wave duration from signal-averaged ECGs was able to 
predict AF in patients with acute myocardial infarction in the 
study of Rosiak and colleagues [26].
M E T H O D O L O G I C A L  C O N S I D E R A T I O N S  
F O R  T H E  E vA L U A T I O N  O F  P  wAv E  D I S P E R S I O N
P wave dispersion constitutes a recent contribution to 
the field of noninvasive electrocardiology and seems to be 
quite promising in the field of AF prediction. However, the 
methodology used to obtain the interlead variation in the P 
waves duration differed between the various studies. Thermal, 
digital, and signal-averaging ECG systems have been used to 
evaluate P wave dispersion which was measured manually 
either on paper or on a high-resolution computer screen from 
12 or 16 ECG leads.
Although alternative methods might exist, the data ana-
lyzed in previous studies show that, manual measurement of 
ECG patterns like the P wave duration and P wave dispersion 
should be preferably performed either with signal-averaging 
ECG systems or with digital ECG recordings displayed on 
a high resolution computer screen [75]. To optimize the P 
wave determination and the calculation of P wave dispersion 
from 12-lead surface ECGs, we use a commercially available 
computer-based ECG system which enables us to record all 12 
ECG leads simultaneously at a sampling rate of 1200 Hz and a 
12bit A/D conversion rate [75]. A sufficient sampling rate and 
amplitude resolution are necessary for a high-resolution ECG 
analysis. From each lead, the average complex is calculated by 
the MEANS (Modular ECG Analysis) system [76]. Individual 
average complexes are stored digitally and displayed on a high 
resolution computer screen. Each lead is separately magnified 
with a magnification of 160mm/s and 60mm/mV [75]. The start 
and the end of the P wave are marked with the cursor on a 
high resolution computer screen. If the baseline noise is >10μV 
and/or the peak to isoelectric line-P wave amplitude <15μV, 
the lead is excluded from the analysis. No attempt is made to 
correct for missing leads and an ECG with  9 measurable 
leads is excluded from the analysis [75]. After the measurement 
of all measurable P waves is completed, P wave dispersion 
is calculated as the difference between the longest and the 
shortest P wave in any of the measured ECG leads.
In a previous study [75], P wave dispersion has shown 
consistent clinically relevant differences between patients 
with history of paroxysmal AF and healthy controls irrespec-
tive of the method used for P wave measurement. A rather 
poor agreement was found in the same study between the 
manual on screen versus on digitizing board measurements 
of P wave dispersion and an acceptable agreement between 
the different methods was shown concerning the measurement 
of the maximum, the mean P wave duration and the standard 
deviation of the P waves duration [75]. Moreover, the mean 
intraobserver error of measurements was found to be high, 
around 20%, for P wave dispersion with no differences be-
tween patients with AF history and healthy controls. Smaller 
intraobserver relative errors were consistently found during 
on screen measurement of P wave dispersion. Similarly high 
interobserver relative errors of P wave dispersion measure-
ments were also demonstrated with smaller errors during on 
screen measurement of P wave dispersion [75].
However, other studies have demonstrated a low error of 
the measurement of P wave dispersion on paper printed ECGs 
[6,8,19,39]. We believe that, P wave dispersion measurement 
performed manually on paper printed ECGs obtained at a 
standard signal size and paper speed is of questionable ac-
curacy and reproducibility [75,77]. To improve the precision 
of measurement of P wave dispersion from 12-lead ECGs 
recorded and stored on paper, scanning and digitizing ECG 
signals from paper records using an optical scanner is a feasible 
and accurate alternative method [78].
The dispersion of the signal-averaged P wave duration 
on the precordial body surface constitutes an alternative ap-
proach to the estimation of the regional differences in atrial 
activation and conduction. The dispersion of the filtered P 
wave duration has been calculated as the difference between 
the longest and the shortest filtered P wave recorded from 
16 different precordial unipolar leads [73,74]. Acceptable 
intraobserver and interobserver errors of the measurement 
of the dispersion of filtered P wave duration were reported 
[73,74]. However, it remains questionable whether the number 
and the location of the electrodes used in those studies would 
be optimal for the accurate estimation of the body surface 
distribution of atrial electrograms.
R A T I O N A L E  A N D  F I E L D S  
F O R  C L I N I C A L  U S E
AF is the most frequent arrhythmia managed in current 
cardiology practice and is responsible for the highest number 
of hospital admissions due to arrhythmias. The treatment of 
AF is considered far from optimal and accurate methods to 
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determine its efficacy are still lacking. Electrocardiography 
constitutes an important diagnostic tool to study AF. The 
presence of prolonged P wave duration filtered or not, identi-
fies patients at risk for the development of AF. However, the 
analysis of the interlead variation in P wave duration seems to 
be required in order to assess the inhomogeneity of electrical 
atrial activity in patients with paroxysmal AF. P wave disper-
sion, which is derived from standard 12-lead ECGs or more 
sophisticated signal-averaged mapping techniques, is supposed 
to reflect the homogeneity of the atrial electrical activity and 
seems quite promising in the field of AF prediction. The 
present review aimed to inform clinicians about the already 
gained experience from the use of this ECG index. Numerous 
studies from many centers have contributed to elucidate the 
rationale and clinical applicability of P wave dispersion. Future 
studies should clarify its role in predicting the risk for AF and 
its ability to guide antiarrhythmic therapeutic strategies. To 
enhance its clinical use some methodological and technical 
problems that still exist should be resolved such as the improve-
ment of the reliability and reproducibility of P wave dispersion 
measurements. The development of automatic methods able 
to accurately determine the P wave duration from standard 
12-lead ECGs may contribute to the widespread use of this 
new ECG marker.
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